Full Press Release Details
| Appendix 3Z |
| Final Director's Interest Notice |
Final Director's Interest Notice
Information or documents not available now must
be given to ASX as soon as available. Information and documents given to ASX becomes ASX's property and may be made public.
Introduced 30/9/2001.
| Name of entity | Alterity Therapeutics Limited |
| ABN | 37 080 699 065 |
We (the entity) give ASX the following information
under listing rule 3.19.A.3 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of director | Brian Meltzer |
| Date of last notice | 17 September 2025 |
| Date that director ceased to be director | 21 November 2025 |
Part 1 - Director's relevant interests in securities
of which the director is the registered holder
In the case of a trust, this includes interests in
the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come
within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.
Part 2 - Director's relevant interests in securities
of which the director is not the registered holder
Note: In the case of a company, interests which come
within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.
In the case of a trust, this includes interests in
the trust made available by the responsible entity of the trust
| Name of holder & nature of interest | Number & class of Securities |
| Note: Provide details of the circumstances giving rise to the relevant interest. | |
| BT PORTFOLIO SERVICES (SMSF) | 326,666 - FULLY PAID ORDINARY SHARES |
Part 3 - Director's interests in contracts
| Detail of contract | N/A |
| Nature of interest | N/A |
| Name of registered holder (if issued securities) | N/A |
| No. and class of securities to which interest relates | N/A |
| + See chapter 19 for defined terms. | |
| 11/03/2002 | Appendix 3Z Page 1 |